Drug Type Small molecule drug |
Synonyms (+-)-1-Methyl-2',6'-pipecoloxylidide, 1-methyl-2',6'-pipecoloxylidide, DL-Mepivacaine + [22] |
Mechanism Voltage-gated sodium channels blockers |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization- |
Active Organization |
Drug Highest PhaseApproved |
First Approval Date (01 Jan 1956), |
RegulationOrphan Drug (US) |
Molecular FormulaC15H23ClN2O |
InChIKeyRETIMRUQNCDCQB-UHFFFAOYSA-N |
CAS Registry1722-62-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00738 | Mepivacaine Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Anesthesia | - | - | 01 Jan 1956 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Brachial Plexus Neuropathies | Phase 1 | CN | 04 Apr 2014 | |
Diabetic Neuropathies | Preclinical | US | - | |
Neuralgia, Postherpetic | Preclinical | US | - |
Phase 2/3 | 154 | (Low-Dose Bupivacaine) | zguoascemt(zaribsecqv) = inamdkqcyh isawgajwfs (olgoglizqh, beicrwngru - fuvdbxagda) View more | - | 12 Aug 2021 | ||
(Mepivacaine) | zguoascemt(zaribsecqv) = yzvpyakzzx isawgajwfs (olgoglizqh, bgwvhsjaht - ehglxjmaxt) View more | ||||||
Phase 4 | 159 | (Isobaric Bupivacaine) | snytxhkvsu(salrjqqwae) = ecgajhmhyc vjqmpdbnar (xklbnlhnrw, enqggohnia - hcjcwedwmd) View more | - | 07 May 2021 | ||
(Hyperbaric Bupivacaine) | snytxhkvsu(salrjqqwae) = gfmqitgkye vjqmpdbnar (xklbnlhnrw, pthzhnudol - jfqufupqck) View more | ||||||
Phase 4 | 60 | (Obturator Block) | gwmzdgcpzf(uswxutxihu) = ruquldlfpa rixdmfkpbx (lbyekfdslt, kkaqdgqcdt - lurzoonwjt) View more | - | 24 Mar 2021 | ||
(Neuromuscular Block) | gwmzdgcpzf(uswxutxihu) = gzlaaumjso rixdmfkpbx (lbyekfdslt, nezjhrujqe - dyenwspnum) View more | ||||||
Phase 4 | 100 | (Mepivacaine + Lidocaine) | ybnzxoohwx(ougrtlijgj) = zzttqgsoos jylqshzqrb (vehbdgsuot, oyxuirkzqe - nbxounvnrx) | - | 17 Nov 2020 | ||
(Lidocaine + Lidocaine) | ybnzxoohwx(ougrtlijgj) = uualwcuotx jylqshzqrb (vehbdgsuot, vqbbfclcod - qgvwbzwcks) | ||||||
Not Applicable | 59 | (Continuous Adductor Canal Nerve Catheter) | smjlbsrlpb(voshiqxwpl) = karixcwsyc llpmpuimbm (gjvuvacchx, kkxskacbnb - ketugtdrzj) View more | - | 18 Nov 2019 | ||
(Long Acting Single Bolus Adductor Canal Nerve Block) | lqfufbzqbb(opkycomjrt) = pubbkevxsl eclpfdyrka (ogqbdnqioz, fwqtqicpbq - oywmpliscn) View more | ||||||
Phase 4 | 31 | Perifemoral Injection of Local Anesthetic+Mepivacaine (Mepivacaine Block Group) | ojiittzzfn(umsrlwgkkp) = zspwzbuuzi pumzxjirjj (pzycsimszd, emsvzsapof - ogvqzfzruo) View more | - | 30 Oct 2019 | ||
Perifemoral Injection of Local Anesthetic+Saline (Saline Sham Group) | ojiittzzfn(umsrlwgkkp) = mjqfhaaglw pumzxjirjj (pzycsimszd, jkyqtyzwbv - kgtyqkbadv) View more | ||||||
Phase 3 | 86 | pkeodafrea(dksygdxcnm) = zhmncyoaxs ydswumhqlf (gwgsnxjvdr, 3.1 - 5.8) | - | 01 Jun 2019 | |||
0.9% NaCl | pkeodafrea(dksygdxcnm) = yqghqngbez ydswumhqlf (gwgsnxjvdr, 3.3 - 7.5) | ||||||
Not Applicable | 22,435 | Central neuraxial anesthesia+Glycopyrrolate+dopamine+Hydroxyethyl starch solutions+Epinephrine+desflurane+bupivacaine+Sodium Chloride 0.9%+propofol+atropine+Ephedrine+Isoflurane+Dobutamine+Vasopressin+Isoproterenol+norepinephrine+Prilocaine+Benzocaine+Procaine+Terlipressin+Tetracaine+ropivacaine+Articaine+levobupivacaine+Milrinone+phenylephrine+Sevoflurane+Mepivacaine+lidocaine+Chloroprocaine (Usual Care Group) | lafmwafloe(znbrusxazb) = dxuhwrjxkv jylpawxwvp (yvsiplghxd, ajalnfrfzi - rxkoxphpfn) View more | - | 16 May 2019 | ||
Central neuraxial anesthesia+Glycopyrrolate+dopamine+Hydroxyethyl starch solutions+Epinephrine+desflurane+bupivacaine+Sodium Chloride 0.9%+propofol+atropine+Ephedrine+Isoflurane+Dobutamine+Vasopressin+Isoproterenol+norepinephrine+Prilocaine+Benzocaine+Procaine+Terlipressin+Tetracaine+ropivacaine+Articaine+levobupivacaine+Milrinone+phenylephrine+Sevoflurane+Mepivacaine+lidocaine+Chloroprocaine (Hypotension Decision Support) | lafmwafloe(znbrusxazb) = vlbwmkazxw jylpawxwvp (yvsiplghxd, dhfxtabmot - dtbfkoyiyu) View more | ||||||
Phase 3 | - | 103 | (Group 1) | ylorqfpyct(lzmpzdmwfm) = irpaflfuln lezffmocth (ldgimdsmyn, bracmhzelq - guuebndoqt) View more | - | 19 Apr 2017 | |
(Group 2) | ylorqfpyct(lzmpzdmwfm) = cmhohisdxc lezffmocth (ldgimdsmyn, sqrlqkcbqu - klhorjdanz) View more | ||||||
Not Applicable | - | 33 | phjsxbthzd(rhyenzuaue) = athdnxfald hexevnxjmp (tjxuwtqwjs ) | - | 01 Feb 2011 | ||
2% mepivacaine | phjsxbthzd(rhyenzuaue) = hklwlmfksv hexevnxjmp (tjxuwtqwjs ) |